FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2009/091/000086 [Registered on: 19/08/2009]
Last Modified On: 26/12/2019
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study
Modification(s)  
Biological 
Study Design  Randomized Factorial Trial 
Public Title of Study
Modification(s)  
To evaluate the efficacy and cost effectiveness of Two Treatment regimens for treating women requiring Invitro Fertilisation 
Scientific Title of Study
Modification(s)  
A Prospective, Multicentric, Randomized, Comparative, Open Label, Parallel Group Phase IV Study To Evaluate The Efficacy, Safety And Cost Effectiveness Of Minimal Stimulation Protocol Compared To Standard Stimulation Protocol For In vitro Fertilization In Indian Population 
Trial Acronym  comparison between different procedure in invitro fertilization 
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
BSV r-hFSH IV 1108  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Sadhana Desai 
Designation   
Affiliation   
Address  IVF & Infertility Clinic, 12, Spring Filed, 1st floor,
19th Vachha Gandhi Road, Gamdevi
Mumbai
MAHARASHTRA
400007
India 
Phone  022-23805845  
Fax  022-23802604  
Email  skdesai38@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Sadhana Desai 
Designation   
Affiliation   
Address  IVF & Infertility Clinic, 12, Spring Filed, 1st floor,
19th Vachha Gandhi Road, Gamdevi
Mumbai
MAHARASHTRA
400007
India 
Phone  022-23805845  
Fax  022-23802604  
Email  skdesai38@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Sadhana Desai 
Designation   
Affiliation   
Address  IVF & Infertility Clinic, 12, Spring Filed, 1st floor,
19th Vachha Gandhi Road, Gamdevi
Mumbai
MAHARASHTRA
400007
India 
Phone  022-23805845  
Fax  022-23802604  
Email  skdesai38@gmail.com  
 
Source of Monetary or Material Support  
Bharat Serums and Vaccines Limited 
 
Primary Sponsor
Modification(s)  
Name  Indian Society of Assisted Reproduction ISAR 
Address  23A 2nd Floor, Elco Arcade,84, Hill road,Bandra (west)Mumbai-400050, INDIA 
Type of Sponsor  Other [Private association] 
 
Details of Secondary Sponsor
Modification(s)  
Name  Address 
Bharat Serums and Vaccines Ltd  17th Floor, Hoechst HouseNariman PointMumbai - 400 021, INDIA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 24  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr. Nayana Patel  Akansksha IVF  Kaival Hospital,-388001
Anand
GUJARAT 
02692253789

nayana@ivfsurrogate.com 
Dr. Parikshit Tank  Ashwini Maternity and Surgical Hospital  ,-
Mumbai
MAHARASHTRA 


 
Dr. Shefali Jain  Asian Institute of Infertility Management & Dr. Shefali Jain Test Tube Baby Centre  10-E, HIG Main road, Near Christian eminent School,LIG Circle, A. B. Road-452001
Indore
MADHYA PRADESH 
07312579595

drsdjain@yahoo.com 
Dr. Hrishikesh Pai  Babies & Us Fertility, IVF & ICSI Centre  2nd Flr, IVF Dept.,Lilavati Hospital, Bandra (W)-400050
Mumbai
MAHARASHTRA 
02226438280

hdpai@hotmail.com 
Dr. Nandita Palshetkar  Babies & Us Fertility, IVF & ICSI Centre  2nd flr, IVF Department ,Lilavati Hospital, Bandra (W)-400050
Mumbai
MAHARASHTRA 
02226438280

nanditapalshetkar@hotmail.com 
Dr. Kamini Rao  Bangalore Assisted Conception Centre  No. 6/7 Kumara Krupa Road,High Grounds-560001
Bangalore
KARNATAKA 
08022260880`

kambacc@vsnl.com 
Dr. Kanthi Bansal  Bansla Hospital & Safal Fertility Foundation  23 Hatkesh Society,,Navrangpura-380014
Ahmadabad
GUJARAT 
08026440365

kanthimbansal@gmail.com 
Dr. Himanshu Bavishi  Bavishi Fertility Institute  Next to Adani CNG & Gajarwala Flats,Paldi Cross Roads, Paldi-380007
Ahmadabad
GUJARAT 
07926631722
07927484334
drhbavishi@gmail.com 
Dr. Jatin Shah  Bombay Fertility Clinic and IVF Centre  Kamaya Polyclinc, 66-C Motiwala Building,Gowalia Tank-400026
Mumbai
MAHARASHTRA 
02223887865
02223873196
drjain2000@yahoo.com 
Dr. Madhuri M. Patil  Dr. Patil's Fertility and Endoscopic centre  No. 1, Uma Admiralty, 1st floor,,Above HDFC Bank, Bannerghatta road-560029
Bangalore
KARNATAKA 
08041201357

drmadhurip@rediffmail.com 
Dr. Abha Majumdar  Genesis Centre  J-431, New Rajendra Nagar,Main Shankar Rd. Market-110060
New Delhi
DELHI 


abhamajumdar@hotmail.com 
Dr. Duru Shah  GynaecWorld  Kwality house, Above chinese room restaurant,Kemps Corner-400026
Mumbai
MAHARASHTRA 
02223802584
02223804839
durushah@hotmail.com 
Dr. Sadhana Desai  IVF and Fertility Centre  12 Spring Filed, 1st floor,,19th Vacha Gandhi Rd, Gamdevi-400007
Mumbai
MAHARASHTRA 
02223805845
022-23802604
skdesai38@gmail.com 
Dr. Rajul Tyagi  JAVITRI HOSPITAL & TEST TUBE BABY CENTRE  ,-
Lucknow
UTTAR PRADESH 


 
Dr. Umesh Jindal  Jindal IVF and Sant Memorial nursing home  #3050 Sector 20/D,Dakshin Marg-160020
Chandigarh
CHANDIGARH 
01722727773
01725086744
unjindal@gmail.com 
Dr. Sujatha Kar  Kar Clinic & Hospital Pvt Ltd  A-32, Unit 4,-751001

 
06742516666
06742530555
suju63@yahoo.com 
Dr. G. A. Ramaraju  Krishna IVF Clinic  Z. P. Junction,,-
Visakhapatnam
ANDHRA PRADESH 
08912538194
08912706712
 
Dr. Jaideep Malhotra  Malhotra Test Tube baby Centre  ,-

 


 
Dr. Mandakini Parihar  Mandakini Fertiliyt Clinic and IVF Centre  48 Swastik park,,Chembur-400071
Mumbai
MAHARASHTRA 
02225296666
02225233672
mandakiniparihar@gmail.com 
Dr. Nalini Mahajan  Mother & child Hospital  D-59, Defense Colony, ,-110024
New Delhi
DELHI 
01124656736
01124521727
nalinimahajan@hotmail.com 
Dr. Manish Banker  Pulse Women's Hospital  108 Swastik Society,Navrangpura-380009
Ahmadabad
GUJARAT 
07926422626
07926422616
mivfg@yahoo.com 
Dr. Shreyas Padfaonkar  Shreays Infetility & IVF Centre  Munshi Estate, ,M. G. Road, Mulund (W)-400080
Mumbai
MAHARASHTRA 
09867780436

shreyas@siivf.com 
Dr. Sanjay Makhwana  Vasundhara Hospital & Fertility Centre  716 E. Road, Behind Durga Bari,Sardarpura-342003
Jodhpur
RAJASTHAN 
02912613981
02912625853
vasundharafertility@yahoo.com 
Dr Mridubhashini Govindrajan  Womens Centre  Sri Ramakrishna hospital Campus,Sarojini Naidu Road-641044
Coimbatore
TAMIL NADU 
04224201000
04224201024
ksg@womenscentreindia.com 
 
Details of Ethics Committee  
No of Ethics Committees= 24  
Name of Committee  Approval Status 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM   
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Submittted/Under Review 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
CLINICOM  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N979||Female infertility, unspecified, Infertility requiring IVF,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  rFSH (Foligraf)  150IU 
Comparator Agent  rFSH (Foligraf)  225IU 
 
Inclusion Criteria
Modification(s)  
Age From  18.00 Year(s)
Age To  37.00 Year(s)
Gender  Female 
Details  1. Women in the age group of 18 37 years (both inclusive) with normal ovulatory cycles
2. Women with body mass index (BMI) between 20 and 30 kg/m2
3. Women with primary or secondary Infertility
4. Women with negative urine pregnancy test (UPT)
5. Women with normal or clinically insignificant hematology and blood chemistry values.
6. Women whose male partner does not require surgical sperm retrieval [Percutaneous epididymal sperm aspiration (PESA) or Testicular epididymal sperm aspiration (TESA)].
7. Women with FSH, LH, Estradiol (E2),Progesterone (P4) at luteal phase, and Prolactin levels within normal range
8. Women with both intact ovaries. Transvaginal ultrasound documenting the presence of both ovaries, without evidence of abnormality (e.g. no endometrioma) and normal adnexa (e.g. no hydrosalpinx) within 6 months before randomization
9. Male with normal sperm motility and sperm count more than 4 million/mL
 
 
ExclusionCriteria 
Details  1. Women with gonadal failure or premature ovarian failure 2. Women with FSH >10 IU/L 3. Women with thyroid or adrenal dysfunction 4. Women with PCOS, endometrioma (endometrial thickness >4mm) or any other active pelvic pathology 5. Women with untreated fibroid tumors of the uterus of <4 cm in size (incompatible with pregnancy), including untreated submucous myoma and 12 weeks adenomyomas 6. Women with >3 previously unsuccessful IVF cycles or previous IVF cycle with unsuccessful fertilization 7. Women with history of recurrent miscarriage 8. Women with tumors of the ovary, breast, uterus, pituitary or hypothalamus and malformations of the sexual organs (incompatible with pregnancy) 9. Women with history of diabetes or hypertension or any other systemic disorder and on treatment for the same 10. Women mentally incompatible for conception 11. Women with history of hypersensitivity to any excipients of the investigational products 12. Women who are taking concomitant medications that might interfere with study evaluations 13. Women who have participated in another study or received any investigational product 30 days prior to enrolment or simultaneous participation in another clinical study 14. Women who are poor responders to FSH 15. Women with complete or partial hysterectomy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Mean percentage of grade 1 oocytes retrieved 2. Mean percentage of fertilization rate   4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1. Mean total dose in IU required to achieve follicle size &#8805;18 mm in diameter (from the day of r-hFSH administration to the Day of Human Chorionic Gonadotropin [HCG] administration) 2. Percentage of Clinical Pregnancy rate 3. Number of mature and immature oocytes 4. Ratio of mature and immature oocytes 5. Number of grade I embryos 6. Percentage of Chemical Pregnancy rate 7. Mean days of stimulation with r-hFSH required to achieve follicle size &#8805;18 mm in diameter 8. Risk of OHSS 9. Incidence & Absolute Frequency of AE?s reported in the trial which were related to study drugs administered in Group A & Group B   4 weeks 
 
Target Sample Size
Modification(s)  
Total Sample Size="210"
Sample Size from India="210" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   Date Missing 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  20/08/2009 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years=""
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Completed 
Recruitment Status of Trial (India)   
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomised open label multi-centre trial to compare the efficacy and safety of the Minimal stimulation protocol vis-a-vis the standard protocol for artificial reproduction (using ICSI) with rFSH (Foligraf), manufactured by Bharat Serums and Vaccines Ltd. The study is being conducted at 24 centres in India. Thr primary outcome is number of grade 1 oocytes and mean percentage of fertilisation rate. The secondary outcomes are percentage of clinical pregnancy, mean dose of rFSH and incidence of AEs.  
Close